CRANE CO (CR) Stock Fundamental Analysis
USA - NYSE:CR - US2244081046 - Common Stock
189.44 USD
+0.44 (+0.23%)
189.44 USD
0 (0%)
Overall CR gets a fundamental rating of 7 out of 10. We evaluated CR against 130 industry peers in the Machinery industry. CR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, CR is valued expensive at the moment. These ratings could make CR a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year CR was profitable.
In the past year CR had a positive cash flow from operations.
Each year in the past 5 years CR has been profitable.
CR had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CR has a better Return On Assets (14.35%) than 93.85% of its industry peers.
Looking at the Return On Equity, with a value of 18.61%, CR belongs to the top of the industry, outperforming 82.31% of the companies in the same industry.
CR has a Return On Invested Capital of 13.88%. This is amongst the best in the industry. CR outperforms 82.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CR is in line with the industry average of 10.24%.
The last Return On Invested Capital (13.88%) for CR is above the 3 year average (9.11%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.35% | ||
| ROE | 18.61% | ||
| ROIC | 13.88% |
ROA(3y)10.39%
ROA(5y)10.5%
ROE(3y)19.31%
ROE(5y)22.01%
ROIC(3y)9.11%
ROIC(5y)8.41%
1.3 Margins
CR has a Profit Margin of 17.33%. This is amongst the best in the industry. CR outperforms 93.85% of its industry peers.
In the last couple of years the Profit Margin of CR has grown nicely.
CR's Operating Margin of 18.33% is amongst the best of the industry. CR outperforms 85.38% of its industry peers.
In the last couple of years the Operating Margin of CR has grown nicely.
The Gross Margin of CR (43.41%) is better than 79.23% of its industry peers.
CR's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.33% | ||
| PM (TTM) | 17.33% | ||
| GM | 43.41% |
OM growth 3Y15.82%
OM growth 5Y3.47%
PM growth 3Y-13.15%
PM growth 5Y27.77%
GM growth 3Y6.84%
GM growth 5Y2.54%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CR is still creating some value.
CR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CR has been reduced compared to 5 years ago.
The debt/assets ratio for CR has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 13.75 indicates that CR is not in any danger for bankruptcy at the moment.
CR has a Altman-Z score of 13.75. This is amongst the best in the industry. CR outperforms 94.62% of its industry peers.
CR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.75 |
ROIC/WACC1.45
WACC9.57%
2.3 Liquidity
A Current Ratio of 3.27 indicates that CR has no problem at all paying its short term obligations.
CR has a better Current ratio (3.27) than 80.00% of its industry peers.
CR has a Quick Ratio of 2.26. This indicates that CR is financially healthy and has no problem in meeting its short term obligations.
CR has a better Quick ratio (2.26) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.27 | ||
| Quick Ratio | 2.26 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.21% over the past year.
Measured over the past years, CR shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.00% on average per year.
Looking at the last year, CR shows a decrease in Revenue. The Revenue has decreased by -7.25% in the last year.
CR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.28% yearly.
EPS 1Y (TTM)20.21%
EPS 3Y-8.02%
EPS 5Y-3%
EPS Q2Q%18.84%
Revenue 1Y (TTM)-7.25%
Revenue growth 3Y1.09%
Revenue growth 5Y-8.28%
Sales Q2Q%-1.34%
3.2 Future
Based on estimates for the next years, CR will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.74% on average per year.
CR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.35% yearly.
EPS Next Y17.73%
EPS Next 2Y14.71%
EPS Next 3Y14.86%
EPS Next 5Y13.74%
Revenue Next Year7.16%
Revenue Next 2Y10.05%
Revenue Next 3Y8.99%
Revenue Next 5Y8.35%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.83, CR can be considered very expensive at the moment.
63.85% of the companies in the same industry are cheaper than CR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CR to the average of the S&P500 Index (25.83), we can say CR is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 27.90, the valuation of CR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CR indicates a slightly more expensive valuation: CR is more expensive than 62.31% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 32.68. CR is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.83 | ||
| Fwd PE | 27.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CR is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, CR is valued a bit cheaper than 67.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.69 | ||
| EV/EBITDA | 24.1 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CR may justify a higher PE ratio.
CR's earnings are expected to grow with 14.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.85
PEG (5Y)N/A
EPS Next 2Y14.71%
EPS Next 3Y14.86%
5. Dividend
5.1 Amount
With a yearly dividend of 0.49%, CR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.83, CR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, CR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.49% |
5.2 History
The dividend of CR decreases each year by -12.19%.
CR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-12.19%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CR pays out 14.07% of its income as dividend. This is a sustainable payout ratio.
DP14.07%
EPS Next 2Y14.71%
EPS Next 3Y14.86%
189.44
+0.44 (+0.23%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners77.38%
Inst Owner Change0%
Ins Owners0.27%
Ins Owner Change-0.16%
Market Cap10.90B
Revenue(TTM)2.11B
Net Income(TTM)365.90M
Analysts82.35
Price Target216.04 (14.04%)
Short Float %1.2%
Short Ratio1.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.49% |
Yearly Dividend0.82
Dividend Growth(5Y)-12.19%
DP14.07%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.41%
Min EPS beat(2)7.02%
Max EPS beat(2)7.79%
EPS beat(4)4
Avg EPS beat(4)4.58%
Min EPS beat(4)0.24%
Max EPS beat(4)7.79%
EPS beat(8)8
Avg EPS beat(8)4.11%
EPS beat(12)12
Avg EPS beat(12)9.6%
EPS beat(16)15
Avg EPS beat(16)7.95%
Revenue beat(2)0
Avg Revenue beat(2)-1.24%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-1.19%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)-1.07%
Revenue beat(8)1
Avg Revenue beat(8)-1.01%
Revenue beat(12)3
Avg Revenue beat(12)-4.21%
Revenue beat(16)5
Avg Revenue beat(16)-0.03%
PT rev (1m)0.48%
PT rev (3m)8.88%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)4.48%
EPS NY rev (1m)0.04%
EPS NY rev (3m)4.3%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.83 | ||
| Fwd PE | 27.9 | ||
| P/S | 5.16 | ||
| P/FCF | 19.69 | ||
| P/OCF | 17.92 | ||
| P/B | 5.54 | ||
| P/tB | 9.65 | ||
| EV/EBITDA | 24.1 |
EPS(TTM)5.77
EY3.05%
EPS(NY)6.79
Fwd EY3.58%
FCF(TTM)9.62
FCFY5.08%
OCF(TTM)10.57
OCFY5.58%
SpS36.69
BVpS34.17
TBVpS19.62
PEG (NY)1.85
PEG (5Y)N/A
Graham Number66.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.35% | ||
| ROE | 18.61% | ||
| ROCE | 17.94% | ||
| ROIC | 13.88% | ||
| ROICexc | 16.92% | ||
| ROICexgc | 32.12% | ||
| OM | 18.33% | ||
| PM (TTM) | 17.33% | ||
| GM | 43.41% | ||
| FCFM | 26.22% |
ROA(3y)10.39%
ROA(5y)10.5%
ROE(3y)19.31%
ROE(5y)22.01%
ROIC(3y)9.11%
ROIC(5y)8.41%
ROICexc(3y)10.78%
ROICexc(5y)10.01%
ROICexgc(3y)18.74%
ROICexgc(5y)19.36%
ROCE(3y)12.01%
ROCE(5y)11.18%
ROICexgc growth 3Y10.29%
ROICexgc growth 5Y0.39%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.99%
OM growth 3Y15.82%
OM growth 5Y3.47%
PM growth 3Y-13.15%
PM growth 5Y27.77%
GM growth 3Y6.84%
GM growth 5Y2.54%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 113.69% | ||
| Cap/Sales | 2.6% | ||
| Interest Coverage | 30 | ||
| Cash Conversion | 139.8% | ||
| Profit Quality | 151.3% | ||
| Current Ratio | 3.27 | ||
| Quick Ratio | 2.26 | ||
| Altman-Z | 13.75 |
F-Score8
WACC9.57%
ROIC/WACC1.45
Cap/Depr(3y)93.58%
Cap/Depr(5y)79.88%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.21%
EPS 3Y-8.02%
EPS 5Y-3%
EPS Q2Q%18.84%
EPS Next Y17.73%
EPS Next 2Y14.71%
EPS Next 3Y14.86%
EPS Next 5Y13.74%
Revenue 1Y (TTM)-7.25%
Revenue growth 3Y1.09%
Revenue growth 5Y-8.28%
Sales Q2Q%-1.34%
Revenue Next Year7.16%
Revenue Next 2Y10.05%
Revenue Next 3Y8.99%
Revenue Next 5Y8.35%
EBIT growth 1Y8.07%
EBIT growth 3Y17.08%
EBIT growth 5Y-5.09%
EBIT Next Year27.82%
EBIT Next 3Y19.79%
EBIT Next 5Y15.28%
FCF growth 1Y219.08%
FCF growth 3Y-20.47%
FCF growth 5Y-6.44%
OCF growth 1Y182.06%
OCF growth 3Y-18.53%
OCF growth 5Y-7.3%
CRANE CO / CR FAQ
What is the fundamental rating for CR stock?
ChartMill assigns a fundamental rating of 7 / 10 to CR.
What is the valuation status of CRANE CO (CR) stock?
ChartMill assigns a valuation rating of 2 / 10 to CRANE CO (CR). This can be considered as Overvalued.
What is the profitability of CR stock?
CRANE CO (CR) has a profitability rating of 9 / 10.
Can you provide the financial health for CR stock?
The financial health rating of CRANE CO (CR) is 9 / 10.
How sustainable is the dividend of CRANE CO (CR) stock?
The dividend rating of CRANE CO (CR) is 3 / 10 and the dividend payout ratio is 14.07%.